🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Looking forward to an amazing kidney week 2022! #ASN #kidneyweek

Come find me at PO774 to discuss our results on donor-derived cell-free DNA in KTR with indication biopsy! #KidneyWk #asn

Hype oder Hoffnung? Plasmaaustausch bei schwerem Covid-19 coliquio.de/wissen/covid-1…

Excited to share our latest work on #suPAR in septic AKI led by Christian Nusshag MD. 👇 suPAR constitutes a perfusion-independent predictor of outcome and is a causal contributor to the disease. I am grateful for the collaborators 🙏 ASCI ⁦Salim S. Hayek, MD⁩ insight.jci.org/articles/view/…

Check out our new data on suPAR's role as an immune-derived biomarker with diagnostic, pathophysiological and therapeutic implications in patients with SA-AKI. Grateful for the amazing collaboration. Jochen Reiser MD PhD Salim S. Hayek, MD Critical Care Jesper Eugen-Olsen insight.jci.org/articles/view/…

What do we treat? Acute liver dysfunction and its complications or lab values? Liver-Support Therapies in Critical Illness—A Comparative Analysis of Procedural Characteristics and Safety mdpi.com/2387254 #mdpijcm via JCM MDPI

The plot thickens! The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney disease | Science Translational Medicine science.org/doi/10.1126/sc… U-M Health Frankel CVC Cardiac Biomarkers Lab Jochen Reiser MD PhD UTMB News

Excited to see our work on quantification of TTVL in KTR undergoing short-term modifications of immunosuppressive therapy out in Transplantation ! One step towards immune monitoring post Tx?#ttvguide journals.lww.com/transplantjour…

Check out our new platform for quantifying cell type-specific viral replication kinetics and antiviral drug efficacy in hantavirus infections. In-cell Western assay to quantify infection with pathogenic orthohanta... sciencedirect.com/science/articl…

ASN Kidney Week 2023! Let’s go Phili…🚀🙏

🚀 Just in time-read our latest results on dd-cfDNA in KTR with indication biopsy published in ESOTtransplant journal Transplant International frontierspartnerships.org/articles/10.33… Come discuss results with me-I will be presenting at American Society of Nephrology #KidnWk today at 04:30pm, room115

Want to hear something about the promising, new kidney function biomarker penKid in ICU patients? Meet me at Poster #PO133 🤓. #KidneyWk #ASN

Christian Nusshag MD Great work! More on PenKid in KTR and DGF this afternoon starting 4:30pm at #KidneyWk room 115 in the oral abstract session Kidney Transplantation-Biomarkers-New and Old 🚀🚀🚀

Check out our work on TTVL to monitor changes in immunosuppressive therapy in KTR at ⁦American Society of Nephrology⁩ #kidneywk Poster PO1060

As a proud European I‘m thrilled to attend this years #ERA24 in sunny #stockholm!☀️ Proud to have received one of the best abstracts with our work on Proenkephalin as a new biomarker for DGF in #kidneytransplantation ⁦Christian Nusshag MD⁩ 🚀

What happens if you buffer hypercapnic ARDS patients via CKRT? Higher HCO3 and more lung-protective ventilation! Happy to share our pilot trial on CO2-adapted kidney replacement therapy in hypercapnic ARDS patients – the BigBIC trial! doi.org/10.1186/s13054…

I’m deeply honored to be a part of Kidney Week 2024! Always an incredible conference with inspiring people. 🙏

Great data on Urine CyTOF to identify potential biomarkers for TCMR in kidneyTX presented by ⁦ninagoerlich⁩ from the ⁦Philipp Enghard⁩ lab ⁦American Society of Nephrology⁩ #kidneywk 🚀 ⁦@NephroIntensivB⁩

Amazing talk by #louise_benning on the impact of induction therapy on TTV load after kidney transplantation #KidneyWk2024

🚨Sepsis is biologically complex—and SA-AKI is no exception. In our new study, we combine transcriptomic endotyping + protein biomarkers to tackle this heterogeneity and improve personalized care in sepsis and associated AKI 🧬🙏 #Sepsis #AKI #CritCare link.springer.com/article/10.118…